Revive Therapeutics Ltd. RVVTF
0.01 USD 0.00 (-10.27%)
Nov 5, 2026, 3:30 PM EST
0.012 Day range 0.0136
0.002 52-week range 0.059
- YTD
- +63.75%
- 1 year
- +45.56%
- Market cap
- 5.82M
- EPS (ttm)
- -0.02
- YTD return
- +63.75%
- 1-year return
- +45.56%
- Volume
- 124.02K
- Avg volume
- 168.56K
- Open
- 0.0136
- Previous close
- 0.0146
- Day's range
- 0.012 – 0.0136
- 52-week range
- 0.002 – 0.059
6M -0.0089 (-40.45%)
News
Revive Therapeutics to Expand Bucillamine IP and Orphan Drug Portfolio Across Medical Countermeasures and Rare Diseases 
Revive Therapeutics Announces Proposed Shares for Debt Settlement 
Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio 
Revive Therapeutics Reports Grant of Options 
Revive Therapeutics Reports Positive Results from DRDC Bucillamine Nerve-Agent Research Study 
Revive Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement 
Revive Therapeutics Announces Proposed Private Placement 
Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures 
Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases 
Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study
Your note
Sign in to keep a note on RVVTF — it syncs with the Stock Master app.